1. Albani S, Carson DA, Roudier J. Genetic and environmental factors in the immune pathogenesis of rheumatoid arthritis. Rheum Dis Clin North Am. 1992. 18:729–740.
2. Toussirot E, Roudier J. Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update. Joint Bone Spine. 2007. 74:418–426.
3. Tosato G, Steinberg AD, Yarchoan R, Heilman CA, Pike SE, De Seau V, et al. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest. 1984. 73:1789–1795.
4. Balandraud N, Roudier J, Roudier C. Epstein-Barr virus and rheumatoid arthritis. Autoimmun Rev. 2004. 3:362–367.
5. Sawada S, Takei M. Epstein-Barr virus etiology in rheumatoid synovitis. Autoimmun Rev. 2005. 4:106–110.
6. Costenbader KH, Karlson EW. Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther. 2006. 8:204.
7. Shim YS, Kim JS, Lee KK, Lee KM, Kim KN. Juvenile rheumatoid arthritis in children with Ebstein-barr virus infection. J Rheum Dis. 2012. 19:19–24.
8. Gear AJ, Venables PJ, Edwards JM, Maini RN, Ansell BM. Rheumatoid arthritis, juvenile arthritis, iridocyclitis and the Epstein-Barr virus. Ann Rheum Dis. 1986. 45:6–8.
9. Hong CY, Lee HS, Henle W, Henle GE. Epstein-Barr virus antibody levels in Koreans. J Korean Med Assoc. 1977. 20:425–428.
10. Oh SH, Lee YA, Moon WY, Ko TS, Park YS, Moon HN, et al. Prevalence of Epstein-Barr virus (EBV) antibody in Korean children. J Korean Pediatr Soc. 1994. 37:804–811.
11. Kanegane H, Wakiguchi H, Kanegane C, Kurashige T, Tosato G. Viral interleukin-10 in chronic active Epstein-Barr virus infection. J Infect Dis. 1997. 176:254–257.
12. Ollier W. Rheumatoid arthritis and Epstein-Barr virus: a case of living with the enemy? Ann Rheum Dis. 2000. 59:497–499.